EZH2 and epithelioid sarcoma: A clear example is an inhibitor of enhancer of zeste homolog 2 (EZH2) histone methyltransferase, tazemetostat, registered in the USA for metastatic or locally advanced unresectable epithelioid sarcoma [128].